Gene: FLCN
Official Full Name: folliculinprovided by HGNC
Gene Summary: This gene is located within the Smith-Magenis syndrome region on chromosome 17. Mutations in this gene are associated with Birt-Hogg-Dube syndrome, which is characterized by fibrofolliculomas, renal tumors, lung cysts, and pneumothorax. Alternative splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00559 | FLCN gRNA3-gRNA4 KO plasmid | FLCN | $850 | |||
GP00562 | FLCN gRNA1-gRNA2 KO plasmid | FLCN | $850 | |||
KO00807 | FLCN Knockout cell line(HCT 116) | Human | FLCN | 1:2~1:4 | Negative | Online Inquiry |
KO09229 | FLCN Knockout cell line (HeLa) | Human | FLCN | 1:3~1:6 | Negative | Online Inquiry |
KO09230 | FLCN Knockout cell line (HEK293) | Human | FLCN | 1:3~1:6 | Negative | Online Inquiry |
KO09231 | FLCN Knockout cell line (A549) | Human | FLCN | 1:3~1:4 | Negative | Online Inquiry |
FLCN Gene Knockout Cell Lines are specialized cellular models engineered to specifically lack the function of the folliculin (FLCN) gene, which is critically involved in cellular energy metabolism and tumor suppression. By employing CRISPR-Cas9 technology, these cell lines enable researchers to investigate the biological roles of FLCN in human health and disease, particularly in the context of tumors associated with Birt-Hogg-Dubé syndrome and other pathological conditions involving aberrations in energy sensing.
The primary function of FLCN is to regulate the mTOR signaling pathway, which is pivotal for controlling cell growth, proliferation, and survival. In the absence of FLCN, cells exhibit altered metabolic profiles and increased susceptibility to oncogenic transformations. By utilizing these knockout cell lines, scientists can elucidate the molecular mechanisms by which FLCN exerts its tumor-suppressive effects and investigate the consequent physiological alterations.
These knockout cell lines are of significant scientific importance, particularly for research into cancer biology, metabolic disorders, and genetic syndromes. They offer a powerful tool for high-throughput drug screening and for the development of targeted therapies, allowing researchers to identify potential therapeutic compounds that can restore normal function or inhibit the growth of FLCN-deficient tumors.
What sets FLCN Gene Knockout Cell Lines apart from other models is their precision in simulating the pathophysiological effects of FLCN loss. Unlike traditional knockdown methods, which may result in residual gene expression, complete knockout ensures a thorough understanding of gene function without ambiguity. This feature is particularly advantageous for researchers aiming to achieve replicable and reliable results.
As a product offering from an organization deeply committed to advancing the field of molecular biology, our FLCN Gene Knockout Cell Lines underscore our expertise in producing high-quality biological tools that empower researchers and clinicians. By integrating cutting-edge technology and a robust understanding of gene functions, we provide exceptional products that meet the evolving needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.